标题/作者	年份
Apixaban for the treatment of venous thromboembolism associated with cancer G Agnelli, C Becattini, G Meyer, A Muñoz, MV Huisman, JM Connors, ... New England Journal of Medicine 382 (17), 1599-1607	2020
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update BJ Schneider, J Naidoo, BD Santomasso, C Lacchetti, S Adkins, ... Journal of clinical oncology 39 (36), 4073-4126	2021
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European heart journal 43 (41), 4229-4361	2022
Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial RD McBane II, WE Wysokinski, JG Le‐Rademacher, T Zemla, A Ashrani, ... Journal of thrombosis and haemostasis 18 (2), 411-421	2020
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer GH Lyman, M Carrier, C Ay, M Di Nisio, LK Hicks, AA Khorana, AD Leavitt, ... Blood advances 5 (4), 927-974	2021
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35	2020
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma AJ Grossberg, LC Chu, CR Deig, EK Fishman, WL Hwang, A Maitra, ... CA: a cancer journal for clinicians 70 (5), 375-403	2020
Venous thromboembolism in cancer patients: a population-based cohort study FI Mulder, E Horvàth-Puhó, N van Es, HWM Van Laarhoven, L Pedersen, ... Blood, The Journal of the American Society of Hematology 137 (14), 1959-1969	2021
Venous thromboembolism F Khan, T Tritschler, SR Kahn, MA Rodger The lancet 398 (10294), 64-77	2021
Metastatic pancreatic cancer: ASCO guideline update DPS Sohal, EB Kennedy, P Cinar, T Conroy, MS Copur, CH Crane, ... Journal of Clinical Oncology 38 (27), 3217-3230	2020
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis FI Mulder, FTM Bosch, AM Young, A Marshall, RD McBane, TJ Zemla, ... Blood, The Journal of the American Society of Hematology 136 (12), 1433-1441	2020
Prevention of venous thromboembolism in 2020 and beyond M Nicholson, N Chan, V Bhagirath, J Ginsberg Journal of Clinical Medicine 9 (8), 2467	2020
Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis M Giustozzi, G Agnelli, J del Toro-Cervera, FA Klok, RP Rosovsky, ... Thrombosis and haemostasis 120 (07), 1128-1136	2020
New treatment strategies for metastatic pancreatic ductal adenocarcinoma RR Singh, EM O’Reilly Drugs 80 (7), 647-669	2020
Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology MB Streiff, B Holmstrom, D Angelini, A Ashrani, A Elshoury, J Fanikos, ... Journal of the National Comprehensive Cancer Network 19 (10), 1181-1201	2021
Update on guidelines for the management of cancer‐associated thrombosis MB Streiff, SA Abutalib, D Farge, M Murphy, JM Connors, G Piazza The Oncologist 26 (1), e24-e40	2021
Cancer-associated venous thromboembolism AA Khorana, N Mackman, A Falanga, I Pabinger, S Noble, W Ageno, ... Nature Reviews Disease Primers 8 (1), 11	2022
Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials F Moik, F Posch, C Zielinski, I Pabinger, C Ay Research and practice in thrombosis and haemostasis 4 (4), e12359	2020
Cancer and embolic stroke of undetermined source BB Navi, SE Kasner, MSV Elkind, M Cushman, OY Bang, LM DeAngelis Stroke 52 (3), 1121-1130	2021
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy H Al-Samkari, JM Connors Hematology 2014, the American Society of Hematology Education Program Book …	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。